相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Medical cannabis attitudes and beliefs among pain physicians
Samer Narouze et al.
REGIONAL ANESTHESIA AND PAIN MEDICINE (2020)
Cannabinoids and Pain: New Insights From Old Molecules
Sonja Vuckovic et al.
FRONTIERS IN PHARMACOLOGY (2018)
Cannabinoid Hyperemesis Syndrome: Public Health Implications and a Novel Model Treatment Guideline
Jeff Lapoint et al.
WESTERN JOURNAL OF EMERGENCY MEDICINE (2018)
The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors
T. Bakas et al.
PHARMACOLOGICAL RESEARCH (2017)
Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors
Rosaria I. Staiano et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Evodiamine suppresses capsaicin-induced thermal hyperalgesia through activation and subsequent desensitization of the transient receptor potential V1 channels
Emiko Iwaoka et al.
JOURNAL OF NATURAL MEDICINES (2016)
An update on PPAR activation by cannabinoids
Saoirse Elizabeth O'Sullivan
BRITISH JOURNAL OF PHARMACOLOGY (2016)
ASTROGLIAL TYPE-1 CANNABINOID RECEPTOR (CB1): A NEW PLAYER IN THE TRIPARTITE SYNAPSE
J. F. Oliveira Da Cruz et al.
NEUROSCIENCE (2016)
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
Fabio Arturo Iannotti et al.
PROGRESS IN LIPID RESEARCH (2016)
Cannabis sativa: The Plant of the Thousand and One Molecules
Christelle M. Andre et al.
FRONTIERS IN PLANT SCIENCE (2016)
Medical cannabis - the Canadian perspective
Gordon D. Ko et al.
JOURNAL OF PAIN RESEARCH (2016)
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
Sumner Burstein
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Cannabis in Cancer Care
D. I. Abrams et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Receptome: Interactions between three pain-related receptors or the Triumvirate of cannabinoid, opioid and TRPV1 receptors
Ferenc Zador et al.
PHARMACOLOGICAL RESEARCH (2015)
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability
Fabio Arturo Iannotti et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Cellular approaches to the interaction between cannabinoid receptor ligands and nicotinic acetylcholine receptors
Murat Oz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum
E. Martinez-Pinilla et al.
EXPERIMENTAL NEUROLOGY (2014)
TRP Channels and Pain
David Julius
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 29 (2013)
Targeting TRP channels for pain relief
Jill-Desiree Brederson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
CANNABINOID AND OPIOID INTERACTIONS: IMPLICATIONS FOR OPIATE DEPENDENCE AND WITHDRAWAL
J. L. Scavone et al.
NEUROSCIENCE (2013)
Amygdala activity contributes to the dissociative effect of cannabis on pain perception
Michael C. Lee et al.
PAIN (2013)
Special Issue on microglia and chronic pain
Claire E. Hulsebosch
EXPERIMENTAL NEUROLOGY (2012)
The Cannabinoid Receptor CB1 Modulates the Signaling Properties of the Lysophosphatidylinositol Receptor GPR55
Julia Kargl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
Wei Xiong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Inhibition of 5-HT3 receptors-activated currents by cannabinoids in rat trigeminal ganglion neurons
Bo Shi et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2012)
The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55
Haleli Sharir et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids
Antonio Luchicchi et al.
MOLECULAR NEUROBIOLOGY (2012)
Involvement of descending serotonergic and noradrenergic pathways in CB1 receptor-mediated antinociception
Ahmet Dogrul et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
Ethan B. Russo
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Heteromultimerization of Cannabinoid CB1 Receptor and Orexin OX1 Receptor Generates a Unique Complex in Which Both Protomers Are Regulated by Orexin A
Richard J. Ward et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia
Wei Xiong et al.
NATURE CHEMICAL BIOLOGY (2011)
The major central endocannabinoid directly acts at GABAA receptors
Erwin Sigel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Adenosine-cannabinoid receptor interactions. Implications for striatal function
Sergi Ferre et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown
Patricia H. Reggio
CURRENT MEDICINAL CHEMISTRY (2010)
Endocannabinoids as Regulators of Transient Receptor Potential (TRP)Channels: a Further Opportunity to Develop New Endocannabinoid-Based Therapeutic Drugs
V. Marzo et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Cannabinoid-opioid interactions during neuropathic pain and analgesia
Ittai Bushlin et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Systemic cannabinoids produce CB1-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT7 and 5-HT2A receptors
Melik Seyrek et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Cannabinoid and Cannabinoid-Like Receptors in Microglia, Astrocytes, and Astrocytomas
Nephi Stella
GLIA (2010)
Signal transduction of the CB1 cannabinoid receptor
Gabor Turu et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2010)
Ligand-Induced Regulation and Localization of Cannabinoid CB1 and Dopamine D2L Receptor Heterodimers
Julie A. Przybyla et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Endocannabinoids Potentiate Synaptic Transmission through Stimulation of Astrocytes
Marta Navarrete et al.
NEURON (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain
Praveen Anand et al.
BRAIN RESEARCH REVIEWS (2009)
The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation
Christopher M. Henstridge et al.
FASEB JOURNAL (2009)
Cannabinoid Type 2 Receptor as a Target for Chronic - Pain
Massimiliano Beltramo
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
Elizabeth J. Rahn et al.
NEUROTHERAPEUTICS (2009)
The Nonpsychotropic Cannabinoid Cannabidiol Modulates and Directly Activates Alpha-1 and Alpha-1-Beta Glycine Receptor Function
Joerg Ahrens et al.
PHARMACOLOGY (2009)
Advances in the field of cannabinoid-opioid cross-talk
Patricia Robledo et al.
ADDICTION BIOLOGY (2008)
Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI
C-L Chin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Evidence for a novel functional role of cannabinoid CB2 receptors in the thalamus of neuropathic rats
M. D. Jhaveri et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level
Gyoengyi Horvath et al.
PAIN (2008)
Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons
Uma Anand et al.
PAIN (2008)
The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain
Penny C. Staton et al.
PAIN (2008)
Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis
Denise Richardson et al.
ARTHRITIS RESEARCH & THERAPY (2008)
GPR55: a new member of the cannabinoid receptor clan?
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
A. Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Identification of GPR55 as a lysophosphatidylinositol receptor
Saori Oka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain
Maulik D. Jhaveri et al.
MOLECULAR NEUROBIOLOGY (2007)
Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance
T. Trang et al.
NEUROSCIENCE (2007)
The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain
Barbara Costa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Regulation of TRP channels: a voltage-lipid connection
B. Nilius et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Endocannabinoids and the control of energy balance
Isabel Matias et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2007)
The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists
G. T. Whiteside et al.
CURRENT MEDICINAL CHEMISTRY (2007)
μ opioid and CB1 cannabinoid receptor interactions:: reciprocal inhibition of receptor signaling and neuritogenesis
Carl Rios et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists
M. Cui et al.
JOURNAL OF NEUROSCIENCE (2006)
Increased sensitivity of desensitized TRPV1 by PMA occurs through PKCε-mediated phosphorylation at S800
Sravan Mandadi et al.
PAIN (2006)
Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes
J. Manzanares et al.
CURRENT NEUROPHARMACOLOGY (2006)
The pharmacology of cannabinoid receptors and their ligands: an overview
RG Pertwee
INTERNATIONAL JOURNAL OF OBESITY (2006)
CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms
M Beltramo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Δ9-Tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors
N Hejazi et al.
MOLECULAR PHARMACOLOGY (2006)
Cannabinoid signalling
DG Demuth et al.
LIFE SCIENCES (2006)
Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain
L. Cristino et al.
NEUROSCIENCE (2006)
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems
D Viganò et al.
PSYCHOPHARMACOLOGY (2005)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Central glucocorticoid receptors modulate the expression of spinal cannabinoid receptors induced by chronic morphine exposure
GW Lim et al.
BRAIN RESEARCH (2005)
Functional aspects and mechanisms of TRPV1 involvement in neurogenic inflammation that leads to thermal hyperalgesia
R Planells-Cases et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2005)
Lipids as regulators of the activity of transient receptor potential type V1 (TRPV1) channels
L De Petrocellis et al.
LIFE SCIENCES (2005)
Agonistic properties of cannabidiol at 5-HT1a receptors
EB Russo et al.
NEUROCHEMICAL RESEARCH (2005)
Cannabinoid-based drugs as anti-inflammatory therapeutics
TW Klein
NATURE REVIEWS IMMUNOLOGY (2005)
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids
MM Ibrahim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide
J Lo Verme et al.
MOLECULAR PHARMACOLOGY (2005)
Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons
G Wotherspoon et al.
NEUROSCIENCE (2005)
Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: A new model of neuropathic pain
JS Walczak et al.
NEUROSCIENCE (2005)
Biochemical pharmacology of the vanilloid receptor TRPV1 - An update
DN Cortright et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
Synergistic interactions between cannabinoid and opioid analgesics
DL Cichewicz
LIFE SCIENCES (2004)
Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation
AG Nackley et al.
JOURNAL OF NEUROPHYSIOLOGY (2004)
Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors
A Quartilho et al.
ANESTHESIOLOGY (2003)
Antinociceptive synergy between Δ9-tetrahydrocannabinol and opioids after oral administration
DL Cichewicz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
CB2 cannabinoid receptor agonists:: pain relief without psychoactive effects?
TP Malan et al.
CURRENT OPINION IN PHARMACOLOGY (2003)
Participation of the opioid system in cannabinoid-induced antinociception and emotional-like responses
R Maldonado et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2003)
A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
DT Wade et al.
CLINICAL REHABILITATION (2003)
Direct inhibition by cannabinoids of human 5-HT3A receptors:: probable involvement of an allosteric modulatory site
M Barann et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors
SM Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cannabinoids: a real prospect for pain relief?
L Iversen et al.
CURRENT OPINION IN PHARMACOLOGY (2002)
Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB1 receptor binding and mRNA levels
S Gonzalez et al.
DRUG AND ALCOHOL DEPENDENCE (2002)
CB1-cannabinoid and μ-opioid receptor co-localization on postsynaptic target in the rat dorsal horn
C Salio et al.
NEUROREPORT (2001)
Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain
SM Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The neurobiology and evolution of cannabinoid signalling
MR Elphick et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2001)
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
RI Wilson et al.
NATURE (2001)
Ultrastructural localization of the CB1 cannabinoid receptor in μ-opioid receptor patches of the rat caudate putamen nucleus
JJ Rodríguez et al.
JOURNAL OF NEUROSCIENCE (2001)
Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists
KJ Powell et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Cellular signal transduction by anandamide and 2-arachidonoylglycerol
AC Howlett et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2000)
Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol
CJ Hillard
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2000)
分享论文
